Evidence map›Paper›PMID 33820992›Full record

ArticleNature structural & molecular biology2021

The selection process of licensing a DNA mismatch for repair.

Rafael Fernandez-Leiro, Doreth Bhairosing-Kok, Vladislav Kunetsky, Charlie Laffeber, Herrie H Winterwerp, Flora Groothuizen, Alexander Fish, Joyce H G Lebbink, Peter Friedhoff, Titia K Sixma and 1 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Nucleic Acids and Electrical Signals.Reviews of physiology, biochemistry and pharmacology · 2025
    Review
  8. Review
  9. Article
  10. Expansion of the MutS Gene Family in Plants.bioRxiv : the preprint server for biology · 2024
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Rafael Fernandez-LeiroMRC Laboratory of Medical Research, Cambridge, UK. rfleiro@cnio.es.ORCID http://orcid.org/0000-0002-7941-0357
Doreth Bhairosing-KokDivision of Biochemistry and Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Vladislav KunetskyInstitute for Biochemistry, Justus-Liebig University, Giessen, Germany.ORCID http://orcid.org/0000-0002-6753-909X
Charlie LaffeberDepartment of Molecular Genetics and Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Herrie H WinterwerpDivision of Biochemistry and Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Flora GroothuizenDivision of Biochemistry and Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Alexander FishDivision of Biochemistry and Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Joyce H G LebbinkDepartment of Molecular Genetics and Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
Peter FriedhoffInstitute for Biochemistry, Justus-Liebig University, Giessen, Germany.
Titia K SixmaDivision of Biochemistry and Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands. t.sixma@nki.nl.ORCID http://orcid.org/0000-0001-6180-0632
Meindert H LamersMRC Laboratory of Medical Research, Cambridge, UK. m.h.lamers@lumc.nl.ORCID http://orcid.org/0000-0002-4205-1338
The Netherlands Cancer Institute · NLErasmus MC · NLJustus-Liebig-Universität Gießen · DEMRC Human Nutrition Research · GBMRC Laboratory of Molecular Biology · GB

Funding

Medical Research Council U105197143
6 · The paper itself

Abstract

DNA mismatch repair detects and removes mismatches from DNA by a conserved mechanism, reducing the error rate of DNA replication by 100- to 1,000-fold. In this process, MutS homologs scan DNA, recognize mismatches and initiate repair. How the MutS homologs selectively license repair of a mismatch among millions of matched base pairs is not understood. Here we present four cryo-EM structures of Escherichia coli MutS that provide snapshots, from scanning homoduplex DNA to mismatch binding and MutL activation via an intermediate state. During scanning, the homoduplex DNA forms a steric block that prevents MutS from transitioning into the MutL-bound clamp state, which can only be overcome through kinking of the DNA at a mismatch. Structural asymmetry in all four structures indicates a division of labor between the two MutS monomers. Together, these structures reveal how a small conformational change from the homoduplex- to heteroduplex-bound MutS acts as a licensing step that triggers a dramatic conformational change that enables MutL binding and initiation of the repair cascade.

Indexed as

Protein ConformationCryoelectron MicroscopyDNADNA Mismatch RepairDNA RepairDNA ReplicationEscherichia coliEscherichia coli ProteinsMutL ProteinsMutS DNA Mismatch-Binding ProteinDNAEscherichia coli ProteinsMutL protein, E coliMutL ProteinsMutS DNA Mismatch-Binding ProteinMutS protein, E coli

Identifiers

PMID33820992
OpenAlexW3146167469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.